Back to
Rockefeller Capital Management L.P.
REGNShowing 8 of 31 quarters
Position history for
Rockefeller Capital Management L.P.'s holdings in Regeneron Pharmaceuticals, Inc.
Yes. Rockefeller Capital Management holds 21,563 shares of REGN (Regeneron Pharmaceuticals), worth $13.4M, as of its Q2 2026 13F filing. It reduced the position by 6,957 shares (-24.4%) from Q1 2026. Rockefeller Capital Management has held REGN in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$13.4M
Current Shares
21,563
Total Value Change
-$89.6M
Total Shares Change
-76,441
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC